Previous Article | Next Article ![]()
Infection and Immunity, April 2000, p. 2276-2285, Vol. 68, No. 4
Division of Infectious Diseases, Veterans
Affairs Greater Los Angeles Healthcare System, Los Angeles,
California 900731; Department of
Medicine, UCLA School of Medicine, Los Angeles, California
900952; National Animal Disease Center,
Agricultural Research Service, U.S. Department of Agriculture,
Ames, Iowa 500103; Biology
Department, University of Southern Indiana, Evansville, Indiana
477124; and University of the West
Indies School of Clinical Medicine and Research,
Barbados5
Received 2 September 1999/Returned for modification 3 November
1999/Accepted 4 January 2000
We report the cloning of the gene encoding the 32-kDa lipoprotein,
designated LipL32, the most prominent protein in the leptospiral protein profile. We obtained the N-terminal amino acid sequence of a
staphylococcal V8 proteolytic-digest fragment to design an oligonucleotide probe. A Lambda-Zap II library containing
EcoRI fragments of Leptospira kirschneri DNA
was screened, and a 5.0-kb DNA fragment which contained the entire
structural lipL32 gene was identified. Several lines of
evidence indicate that LipL32 is lipid modified in a manner similar to
that of other procaryotic lipoproteins. The deduced amino acid sequence
of LipL32 would encode a 272-amino-acid polypeptide with a
19-amino-acid signal peptide, followed by a lipoprotein signal
peptidase cleavage site. LipL32 is intrinsically labeled during
incubation of L. kirschneri in media containing
[3H]palmitate. The linkage of palmitate and the
amino-terminal cysteine of LipL32 is acid labile. LipL32 is completely
solubilized by Triton X-114 extraction of L. kirschneri;
phase separation results in partitioning of LipL32 exclusively into the
hydrophobic, detergent phase, indicating that it is a component of the
leptospiral outer membrane. CaCl2 (20 mM) must be present
during phase separation for recovery of LipL32. LipL32 is expressed not
only during cultivation but also during mammalian infection.
Immunohistochemistry demonstrated intense LipL32 reactivity with
L. kirschneri infecting proximal tubules of hamster
kidneys. LipL32 is also a prominent immunogen during human
leptospirosis. The sequence and expression of LipL32 is highly
conserved among pathogenic Leptospira species. These findings indicate that LipL32 may be important in the pathogenesis, diagnosis, and prevention of leptospirosis.
Leptospirosis is considered to be
the most widespread zoonosis in the world (Centers for Disease Control,
http://www .cdc.gov/ncidod/dbmd/diseaseinfo/leptospirosis_t.htm, 1998). Renal
tubular infection with pathogenic Leptospira species has
been documented for a wide variety of wild and domestic animals. Infections are typically transmitted to humans through contact with
water or soil contaminated with the urine of infected animals. It is
likely that the wide distribution of Leptospira species reflects the ability to survive in diverse environmental conditions combined with genetic adaptation, which is reflected in the plasticity of the leptospiral genome (40). Pathogenic
Leptospira species are capable of surviving as free-living
bacteria for extended periods of time after urinary shedding.
Inactivated whole-cell leptospiral vaccines have been in use for many
years in an effort to control disease in animals and exposure to humans
(35). However, currently available leptospiral vaccines are
ineffective at preventing either disease or infection in cattle
(5-7) and produce only short-term immunity in other animals
(35). The immunity provided by these vaccines is based on
the lipopolysaccharide (LPS) carbohydrate serovar determinant; there is
little cross-protection against infection with the more than 250 different leptospiral serovars that are now known to exist (A.F.
Kaufmann et al.,
http://www.pasteur.fr/recherche/Leptospira/Strains.html, 1999).
Because of the deficiencies of LPS-based vaccines, protein components
of the leptospiral outer membrane represent an important approach to
the development of alternative immunoprotection strategies. Studies
suggest that the leptospiral outer membrane has a relatively complex
protein profile (10, 18, 25, 41). To date, only a few
leptospiral outer membrane proteins have been characterized in detail,
including a porin, OmpL1 (15, 29), and two lipoproteins, LipL36 (16) and LipL41 (31). The most prominent
band in the leptospiral total protein profile is a protein with a
molecular mass of approximately 32 kDa. Zuerner et al. have shown that
this major outer membrane protein (MOMP) could be solubilized by
extraction of the outer membrane with the nonionic detergents Triton
X-100 and Triton X-114 and was the most prominent antigen identified by
infection-derived swine sera in the Triton X-114 detergent phase
(41).
Many of the most abundant proteins in spirochetes are lipoproteins,
including TpN47 of Treponema pallidum (12, 13),
OspA of Borrelia burgdorferi (4, 8), the Vmp
proteins of the relapsing Borrelia fever (11,
30), and SmpA of Brachyspira hyodysenteriae
(37). In this report we describe LipL32, the MOMP of
pathogenic Leptospira spp. Evidence is presented that LipL32
is a lipoprotein covalently modified at its amino-terminal cysteine by
fatty acid(s). We also examined infected hamster kidney tissue and
clinical leptospirosis sera to provide documentation that LipL32 is
expressed not only during cultivation but also during mammalian infection.
(Portions of this work were presented at the 99th General Meeting of
the American Society for Microbiology in Chicago, Ill., May 30 to June
3, 1999.)
Bacterial strains, media, and plasmids.
Leptospira
kirschneri RM52 (36) and other leptospiral strains were
obtained from the National Leptospirosis Reference Center (National
Animal Disease Center, Agricultural Research Service, U.S. Department
of Agriculture, Ames, Iowa). Most of the leptospiral strains used in
this publication are described in a recent DNA relatedness study
(9). Leptospires were cultivated in Johnson-Harris bovine
serum albumin-Tween 80 medium (Bovuminar PLM-5 Microbiological Media;
Intergen) (21). Escherichia coli DH5 Gel electrophoresis and immunoblotting.
Samples for sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) were
solubilized in final sample buffer (FSB) composed of 62.5 mM Tris
hydrochloride (pH 6.8), 10% glycerol, 5% 2-mercaptoethanol, and 2%
SDS. Proteins were separated on a 12% gel with a discontinuous buffer
system (22) and stained with Coomassie brilliant blue or
were transferred to nitrocellulose (Schleicher & Schuell) for
immunoblotting. For antigenic detection on immunoblots, the
nitrocellulose was blocked with 5% nonfat dry milk in 0.1 M
phosphate-buffered saline (PBS; pH 7.4)-0.1% Tween 20 (PBS-T),
incubated for 1h with antiserum diluted 1:5,000 (unless otherwise
noted) in PBS-T, and probed with donkey anti-rabbit antiserum
conjugated to horseradish peroxidase (Amersham). Samples containing
E. coli expressing full-length LipL32 were separated in 10%
Tris-tricine gels (28), and the proteins were transferred to
Immobilon-P (Millipore Corp., Bedford, Mass.) for immunoblotting (performed as described above except that the secondary antibody was
horseradish peroxidase-conjugated anti-rabbit antiserum obtained from
Kirkegaard and Perry Laboratories, Gaithersburg, Md.). Antigen-antibody binding was detected by using the Enhanced Chemiluminescence System (ECL; Amersham). Blots were incubated in ECL reagents for 1 min and
then exposed to XAR-5 film (Kodak).
Amino acid sequencing of an internal polypeptide fragment.
L. kirschneri strain RM52 cells (4 × 1011)
were washed two times in PBS and resuspended in 30 ml of ice-cold TENP
buffer (50 mM Tris, pH 8.0; 1 mM EDTA; 100 mM NaCl; 0.1 mM
phenylmethylsulfonyl fluoride [PMSF]). The cells were disrupted by
tip sonication. The membrane fraction was recovered by centrifugation
for 20 min at 12,000 × g and washed once in TENP
buffer. The membrane proteins were separated on a 12.5% SDS-PAGE gel.
A test strip was stained with Coomassie brilliant blue in order to
locate the 32-kDa band, which was cut out of the remainder of the gel
and loaded onto a second SDS-PAGE gel in the presence of staphylococcal
V8 protease at a concentration of 100 µg ml Southern blot analysis.
L. kirschneri DNA was prepared
by the method of Yelton and Charon (39). Leptospiral DNA was
digested with EcoRI and electrophoresed in a 1.0% agarose
gel. After depurination, denaturation, and neutralization, the DNA was
transferred to a nylon filter (Zeta-Probe; Bio-Rad) by the method of
Southern (27). Filters were prehybridized for 3 h at
37°C in buffer containing 6× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate), 1× Denhardt's solution, 0.05% sodium PPi, 0.5% SDS, and 100 µg of denatured salmon sperm DNA
per ml. Two degenerate oligonucleotides, 32A-1 and 32A-2, were designed based upon the first 8 and last 8 amino acids, respectively, of a
32-amino-acid sequence of a proteolytic fragment of LipL32. The
sequence of oligonucleotide 32A-1 was GDCAYAAYAARTAYAAYWSYYT. The
sequence of oligonucleotide 32A-2 was AARAAYATHGAYACNAARAARYT. Oligonucleotides 32A-1 and 32A-2 were prepared commercially (Gibco Life
Technologies) and used to amplify the intervening region of the
lipL32 gene. The 96-bp amplification product was
radiolabeled by PCR amplification in the presence of
[32P]dCTP. The filters were then hybridized overnight at
42°C with radiolabeled probe. After hybridization, the filters were
washed at 42°C in 2× SSC-0.5% SDS.
Cloning and sequencing of the lipL32 gene.
Standard recombinant DNA procedures were performed as described earlier
(27). Restriction endonuclease digests were performed as
recommended by the suppliers (New England Biolabs and Promega). EcoRI fragments of L. kirschneri genomic DNA were
ligated into the Lambda-Zap II vector (Stratagene). The ligated DNA was
packaged with Gigapack II Gold packaging extract (Stratagene) and
stored in 0.3% chloroform at 4°C. The plaque titer was determined by infecting E. coli PLK F' (Stratagene). Plaques were plated,
transferred to filters in duplicate, and processed as previously
described (15). Filters were probed with the 96-bp amplified
lipL32 gene fragment described above using the same
hybridization and washing conditions as in the Southern hybridization.
Recombinant pBluescript SK(
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
The Leptospiral Major Outer Membrane Protein LipL32
Is a Lipoprotein Expressed during Mammalian Infection
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
[supE44
lacU169 (
80 lacZ
M15)
hsdR17 recA1 endA1 gyrA96 thi-1 relA1] was used as the host
strain for transformations of recombinant DNA. E. coli
PLK-F' (recA lac mcrA mcrB hsdR gal supE [F' proAB
lacIqZ
M15 Tn10 (Tetr)]) was
used as the host strain for infection with the Lambda-Zap II vector
(Stratagene). E. coli PLK-F' and the ExAssist helper phage
were used for in vivo excision of the pBluescript phagemid (Stratagene). E. coli SOLR
(e14
[mcrA],
[mcrCB-hsdSMR-mrr)171 sbcC recB recJ
umuC::Tn5[Kanr] uvrC lac
gyrA96 relA1 thi-1 endA1
r [F' proAB
lacIqZ
M15], Su
[nonsuppressing])
was used as the host strain for replication of the excised pBluescript
phagemid from the Lambda-Zap II vector (Stratagene). E. coli
BLR(DE3)/pLysS [F
ompT hsdSB
(rB
mB) gal dcm
(srl-recA)306::Tn10(TcR)
(DE3) pLysS(CmR)] (Novagen) was used as the host strain for the pRSET
expression vector (Invitrogen). The DE3 lysogen of E. coli
JM109 (Promega) was used as the host strain for pET-15b (Novagen).
E. coli cells were routinely grown in Luria-Bertani broth or
on Luria-Bertani agar, unless otherwise mentioned (27).
1 (Sigma).
The proteins were allowed to migrate into the stacking gel by
electrophoresis, and the current was disconnected for 45 min, followed
by completion of electrophoresis. The polypeptide fragments were
subjected to SDS-PAGE, transferred to Trans-Blot PVDF Protein
Sequencing Membrane (Bio-Rad, Richmond, Calif.) and submitted to the
UCLA Protein Microsequencing Facility. N-terminal amino acid sequence
analysis was performed on a Porton 1090-E gas-phase sequenator with
on-line detection of PTH amino acids.
) clones were recovered from phage
producing positive plaques by in vivo excision according to the
manufacturer. After restriction mapping, appropriate DNA fragments were
subcloned into pBluescript KS and sequenced at the UCLA Core DNA
Sequencing Facility by the dideoxy chain termination method with
fluorescein-labeled dideoxy nucleotides (Applied Biosystems).
Antisera. Antisera to OmpL1 and LipL41 were prepared as previously described (15, 31). Briefly, New Zealand White rabbits were immunized with purified His6 fusion proteins, expressed by E. coli JM109 (Invitrogen) transformed with the pRSET plasmid (Invitrogen) containing either the ompL1 gene or the lipL41 gene (15, 31). Antiserum prepared to a 2% Triton X-114 outer membrane extract of L. interrogans serovar pomona strain RZ11 was used in an immunoblot analysis of E. coli harboring pRZ1132K.
Antiserum to LipL32 was prepared as follows. The PCR was used to amplify the portion of the lipL32 gene encoding the mature protein beginning with the first residue after the amino-terminal cysteine. The 5' oligonucleotide contained the nucleotide sequence coding for the six amino acids following the amino-terminal cysteine of mature LipL32, including a XhoI restriction endonuclease site (underlined): 5'-TTA CCG CTC GAG GTG CTT TCG GTG GTC TGC-3'. The 3' oligonucleotide contained the nucleotide sequence coding for the five carboxy-terminal amino acids and the lipL32 stop codon, including a SmaI restriction endonuclease site (underlined): 5'-TGT TAA CCC GGG TTA CTT AGT CGC GTC AGA-3'. L. kirschneri genomic DNA was used as template. The 782-bp amplified lipL32 gene was digested with XhoI and SmaI and ligated into pRSETc (Invitrogen) digested with XhoI and PvuII. The resulting construct, pRSETc-LipL32, was transformed into E. coli BLR(DE3)/pLysS (Novagen). Expression of the His6-LipL32 fusion protein was achieved by isopropyl-
-D-thiogalactopyranoside (IPTG; Sigma)
induction. The His6-LipL32 fusion protein was solubilized in 6 M guanidine and purified by affinity chromatography using Ni2+-nitrilotriacetic acid-agarose (Qiagen) and dialyzed in
PBS containing 10% glycerol, 0.3% Triton X-100, and 0.025% sodium
azide. The purified His6-LipL32 fusion protein was loaded
onto an SDS-PAGE gel. After electrophoresis, the
His6-LipL32 band containing approximately 150 µg of
protein was cut out of the acrylamide gel, dessicated, ground to
powder, mixed with Freund's complete adjuvant, and inoculated subcutaneously and intramuscularly into a New Zealand White male rabbit. Additional immunizations with approximately 150 µg of His6-LipL32 fusion protein in Freund's incomplete adjuvant
were given at 4 and 8 weeks after primary immunization. The rabbit was
bled 10 weeks after the primary immunization.
[3H]palmitate radiolabeling and immunoprecipitation of native LipL32. A 35-ml culture containing 5 × 107 L. kirschneri cells per ml in the log phase of growth was intrinsically labeled by addition of [9,10(n)-3H]palmitate (250 µCi; 60 Ci/mmol; Amersham), followed by further incubation in a shaker incubator at 30°C for 48 h until the bacterial concentration reached 109/ml. Organisms were washed in 5 mM MgCl2 in PBS. A sample for immunoprecipitation containing 8 × 109 L. kirschneri cells was resuspended in 1.25 ml of 10 mM Tris HCl (pH 8.0)-10 mM EDTA-1 mM PMSF. To this suspension was added 12.5 µl of 10% protein-grade Triton X-100 (Calbiochem), followed by gentle agitation for 30 min at 4°C. The insoluble material was removed by centrifugation at 16,000 × g for 10 min. To the supernatant was added 0.2 ml of LipL32 rabbit antiserum and 0.2 ml of a slurry of staphylococcal protein. A-Sepharose CL-4B (Sepharose-SpA) (Sigma). The suspension was gently agitated for 1 h. The Sepharose-SpA-antibody-antigen complexes were washed twice in 0.1% Triton X-100 in 10 mM Tris HCl (pH 8.0)-20 mM CaCl2-150 mM NaCl and then resuspended in FSB. After SDS-PAGE, gels were prepared for autoradiography by being soaked in Amplify (Amersham), dried, and exposed to Tritium film (Amersham). In some cases, gels were stained with Coomassie brilliant blue and destained in 10% acetic acid-45% methanol prior to being soaked in Amplify (Amersham), dried, and exposed to Tritium film (Amersham).
Triton X-114 extraction of L. kirschneri. L. kirschneri was extracted with 1% Triton X-114 by a modification of the method described previously (18). In brief, culture-attenuated L. kirschneri cells were washed in PBS-5 mM MgCl2 and then extracted in the presence of 1% protein grade Triton X-114 (Calbiochem)-150 mM NaCl-10 mM Tris (pH 8)-1 mM EDTA at 4°C. The insoluble material was removed by centrifugation at 17,000 × g for 10 min. After centrifugation, 20 mM CaCl2 was added to half of the supernatant. Phase separation was performed by warming the supernatant to 37°C and subjecting it to centrifugation for 10 min at 1,000 × g. The detergent and aqueous phases were separated and precipitated with acetone.
Expression of full-length LipL32 in E. coli. The lipL32 amplicon was generated with primers P662 and P663 by using template DNA from strain RZ11 and cloned into the pCRII plasmid vector (Invitrogen), resulting in plasmid pRZ1132K. In pRZ1132K, lipL32 is oriented downstream of the lacZ promoter. E. coli INV?' cells harboring pRZ1132K or pCRII were grown to stationary phase in DYT broth (24). Cells were harvested by centrifugation, and membrane and cytoplasmic fractions were prepared according to the method of Weigel et al. (38).
Immunohistochemistry. The methods used to perform immunohistochemistry and to obtain L. kirschneri-infected hamster kidney tissue have been previously described (3). In brief, 5-week-old Golden Syrian hamsters (Harlan Sprague-Dawley), in groups of three, were inoculated intraperitoneally with 105 virulent L. kirschneri RM52. Moribund hamsters were euthanized; liver and kidney tissues were removed, fixed in formalin, and paraffin embedded. Hamsters surviving 28 days after challenge were euthanized, and the liver and kidney tissues were removed, fixed in formalin, and paraffin embedded. Tissue sections were stained with hematoxylin and eosin or silver stain by the technique of Steiner and Steiner (32).
Serial 5-µm sections of kidney taken 10 and 28 days after infection with L. kirschneri were cut. Tissue sections were placed on Pro-Bond Plus slides. Paraffin was removed from sections with xylene and ethanol by using standard procedures. Tissues were pretreated with 0.1% trypsin in 0.1 M Tris HCl (pH 7.6) with 0.1% CaCl2 for 5 min at 37°C. Nonspecific staining of tissue sections was blocked by using 10% normal goat serum with incubation at room temperature for 20 min prior to incubation overnight at 4°C with primary antibody. Anti-LipL32 antiserum was used at a 1:6,000 dilution. Controls included "negative" primary antibody, normal rabbit serum, and hyperimmune serum on kidney sections from uninfected hamsters. Unbound primary antibody was removed, and tissues were incubated at room temperature for 30 min with biotinylated goat anti-rabbit immunoglobulin (Vector). After being washed, sections were incubated for 20 min at room temperature with supersensitive streptavidin-alkaline phosphatase (Biogenex). Enzyme reactions were developed by using new Fuchsin (Biogenex). All slides were counterstained with hematoxylin before dehydration in alcohols and propar (xylene substitute), and coverslips were then mounted. Smears of organisms from actively growing cultures were processed as tissue sections without the removal of paraffin.ELISA. Convalescent sera from five patients with culture-proven infection due to L. kirschneri serovar bim were used to compare the enzyme-linked immunosorbent assay (ELISA) reactivity with five leptospiral His6 fusion proteins. Immulon microtiter plates (Dynatech) were coated at 37°C overnight with 125 ng of purified His6 fusion proteins in 0.05 M sodium carbonate buffer (pH 9.6). The plates were washed three times with PBS containing 0.05% Tween 20, followed by the addition of 200 µl of blocking buffer (PBS containing 0.05% Tween 20 and 1% nonfat dried milk), and were then incubated at 37°C for 1 h. After removal of the blocking buffer, 100 µl of antisera diluted 1:100 with blocking buffer was added, and the plates were incubated at 37°C for 2 h. After washing the plates three times, 100 µl of 1:5,000-diluted sheep anti-human immunoglobulin G conjugated to horseradish peroxidase (Amersham) was added, and the plates were incubated at 37°C for 2 h. After three more washes, 100 µl of 3,3',5,5'-tetramethylbenzidine substrate was added, and the plates were incubated at 37°C for 20 min on an orbital shaker. Then, 100 µl of a 1 M solution of sulfuric acid was added to stop the reaction. The absorbance was read at a wavelength of 450 nm with a microplate reader (model 550; Bio-Rad). Each serum sample was tested four separate times. Absorbance readings were normalized by subtracting the value obtained from antigen-negative control wells. Statistical analysis was performed by using the two-tailed Student's t test for samples with unequal variance.
Nucleotide sequence accession numbers. The nucleotide sequence of the lipL32 gene from L. kirschneri serovar grippotyphosa strain RM52 has been deposited in the GenBank database under the accession number AF121192. The nucleotide sequences of the lipL32 genes of L. interrogans serovar pomona strain RZ11, L. borgpetersenii serovar hardjo strain 203, L. santarosai serovar tropica strain CA299, and L. noguchii serovar fortbragg strain Fort Bragg have been deposited in the GenBank database under accession numbers AF181553, AF181554, AF181555, and AF181556, respectively. The nucleotide sequence of the lipL32 gene from L. interrogans serovar lai had previously been deposited in the GenBank database under accession number LIU89708.
| |
RESULTS |
|---|
|
|
|---|
Cloning and sequence analysis of the lipL32 gene.
Staphylococcal V8 protease digestion of LipL32 resulted in two
fragments which comigrated by SDS-PAGE with an apparent molecular mass
of 20 kDa. Because the two fragments were present in unequal amounts,
N-terminal amino acid sequence analysis of the 20-kDa band revealed two
sequences: AFKAATPEEKSM and RHNKYNSLTRIKIPNPPKSFDDLKNIDTKKLL. A
PCR-amplified 96-bp probe based on the longer sequence bound to a
single 5.0-kb band in EcoRI digests of total genomic
L. kirschneri serovar grippotyphosa strain RM52 DNA.
Restriction mapping, Southern blot analysis, and DNA sequencing
revealed that the entire lipL32 gene is encoded by the
5.0-kb EcoRI fragment (Fig.
1). A BLAST search of the GenBank
database revealed a nearly 99% identical gene of L. interrogans serovar lai (GenBank accession number LIU89708) (1; BLAST Sequence Similarity Searching,
http://www.ncbi.nlm.nih.gov/BLAST/, 1998). The
L. interrogans lipL32 homolog was isolated and sequenced by
Kim et al. on a DNA fragment containing the sphH
sphingomyelinase gene by screening a library of leptospiral DNA
fragments using the leptospiral sphA gene as a probe (M. J. Kim et al., Meet. Int. Leptospirosis Soc., 1996). Besides
sphH, two other genes were found in proximity to
lipL32. A 398-bp open reading frame (ORF), ORF-1, is located
232 bp upstream of lipL32. Although ORF-1 and
lipL32 are in the same orientation, ORF-1 is followed by a 15-bp inverted repeat, which may function as a rho-independent transcription terminator, suggesting that ORF-1 and lipL32
are not cotranscribed. However, E. coli
70
consensus
35 and
10 promoter regions were not found upstream of
lipL32. Upstream of ORF-1 and oriented in the opposite
direction is a gene which is highly homologous to the
S-adenosylmethionine synthetase genes of a variety of
gram-negative and gram-positive bacteria.
|
|
3 position relative to cysteine is less
common than leucine in signal peptidase II cleavage sites, but there
are at least eight other examples of isoleucine occurring at this
position in bacterial lipoproteins, including OspE, OspF, ErpG, BBA59,
and BBA60 of B. burgdorferi, EnvC and ExcC of E. coli, and Lpp20 of Helicobacter pylori (alignment
available upon request). When LipL32 is expressed in E. coli, processing is incomplete, and the recombinant LipL32 is
equally distributed between the membrane and cytoplasmic fractions of
E. coli (data not shown). This result suggests either that LipL32 secretion was inefficient in E. coli, that the level
of LipL32 synthesis using pRZ1132K had overwhelmed the E. coli secretory apparatus, or there was a combination of both effects.
After cleavage of the 19-amino-acid signal peptide by leptospiral
signal peptidase II, the mature polypeptide would have a predicted
molecular mass of 27.6 kDa. Staphylococcal V8 protease is known to
cleave peptides following acidic amino acids. The predicted amino acid
sequences following aspartate residue 115 and glutamate residue 173 are
identical to those obtained from N-terminal amino acid sequencing of
proteolytic fragments of the native protein. Beginning at residue 161 there is an unusual cluster of seven aspartate residues in a span of
eight amino acids, a finding reminiscent of the six-aspartate cluster
of LipL36 (16). The secondary structure of LipL32 is
predicted to be 24% alpha-helix and 24% beta-sheet by using the GOR
secondary structure prediction method version IV (14;
P. B.-I., Lyonnais, GOR IV Secondary Structure,
http://pbil.ibcp.fr/cgi-bin/npsa-automat.pl?page=gor4.html, 1999). The relatively low amount of alpha-helical structure is consistent with the finding of only 10 potential helix-stabilizing salt
bridges conforming to the "N+4" rule (23). This is in
contrast to LipL41, which has 22 potential salt bridges and is
predicted to be 60% alpha-helix (31).
Expression of LipL32 in Leptospira species.
To
address the level and distribution of LipL32 expression, immunoblot
analysis was performed on a panel of Leptospira species, using antiserum from a rabbit immunized with purified
His6-LipL32 (Fig. 3). The
LipL32 antiserum is reactive with a single band with a molecular mass
of 32 kDa, demonstrating the specificity of the LipL32 antiserum. The
molecular mass and amount of LipL32 expressed among all seven
pathogenic Leptospira species is highly conserved. LipL32 is
expressed in relatively the same amount by all leptospiral pathogens
tested. There was a positive correlation between leptospiral
pathogenicity and reactivity with antiserum to LipL32. No LipL32 was
detected in the nonpathogenic Leptospira species L. biflexa, L. meyeri, and L. wolbachii or in
the related nonpathogen L. illini.
|
Behavior of LipL32 during Triton X-114 extraction and phase
partitioning.
We analyzed the behavior of L. kirschneri
LipL32 in the nonionic detergent Triton X-114 (Fig.
4). We found that extraction of the
leptospiral outer membrane with Triton X-114 resulted in complete
solubilization of LipL32. No LipL32 was seen in the detergent-insoluble pellet. When 20 mM CaCl2 was added to the
detergent-solubilized material prior to phase partitioning, LipL32 was
found to partition exclusively into the detergent phase. Lipoproteins
characteristically partition into the Triton X-114 detergent phase
because of the hydrophobicity of the fatty acids. In contrast to
LipL41, LipL32 was found to be completely absent from the detergent
phase when phase partitioning was performed without addition of
CaCl2. Comparison of the Coomassie brilliant blue-stained
gel (Fig. 4A) with the immunoblot probed with LipL32 and LipL41
antisera (Fig. 4B) demonstrates that LipL32 is the most prominent
protein in the leptospiral protein profile. The results presented here
for L. kirschneri LipL32 mirror those found with the
previously described L. interrogans 31-kDa MOMP, strongly
indicating that they are the same protein (41).
|
Specificity of LipL32 antiserum. The specificity of the LipL32 antiserum has been demonstrated both by one-dimensional (Fig. 3) and two-dimensional (data not shown) immunoblots. Preimmune serum (prior to rabbit immunization with purified, recombinant protein) was tested and found not to be reactive with any leptospiral antigens (data not shown). The LipL32 antiserum was prepared by the same method and with the same adjuvant as that used in the preparation of antisera specific for several other leptospiral outer membrane proteins, including OmpL1 (15) and the lipoproteins LipL36 (16) and LipL41 (31). Our prior studies show that each of these antisera react only with the unique protein used in the immunization and not with the 32-kDa antigen identified by the LipL32 antiserum. Prior immunoprecipitation experiments showed that LipL36 and LipL41 antisera selectively immunoprecipitate proteins of the correct molecular mass; in neither case did immunoprecipitation of a 32-kDa protein occur (17, 31). In addition, immunohistochemistry studies with L. kirschneri-infected hamster kidney sections demonstrated differential reactivity; OmpL1 and LipL41 antisera were positive, while LipL36 antiserum was negative (3). These findings confirm the specificity of the antisera used in our immunoprecipitation and immunohistochemistry experiments.
L. kirschneri acylates LipL32.
Intrinsic labeling
of L. kirschneri with [3H]palmitate resulted
in the incorporation of label in leptospiral LipL32 immunoprecipitated with LipL32 antiserum (Fig. 5, lane 1).
When an SDS-PAGE gel containing the same material was stained with
Coomassie brilliant blue in a solution containing 10% acetic acid, the
immunoprecipitated LipL32 could be visualized (Fig. 5, lane 3), but it
was no longer labeled (Fig. 5, lane 2), indicating that the chemical
bond between [3H]palmitate and the N-terminal cysteine of
LipL32 is acid labile. This experiment also demonstrates that intrinsic
labeling of leptospiral LipL32 with [3H]palmitate does
not involve the incorporation of tritium into amino acid biosynthetic
pathways.
|
Immunohistochemistry with antiserum specific for LipL32.
Leptospires within the proximal tubules of kidney sections obtained 10 and 28 days after infection with virulent L. kirschneri stained positive with LipL32 antiserum. Immunohistochemical
visualization of discrete organisms is possible at 10 days after
infection (Fig. 6A). Staining was more
intense at 28 days than at 10 days, in correlation with the greater
burden of organisms present at the later time point (3). At
28 days after infection, adherent organisms were detected as a
continuous rim of intense staining lining the luminal surface of the
tubular epithelial cells (Fig. 6B). In contrast to the distribution of
leptospiral LPS or OmpL1 (3), little LipL32 antigen was
observed at the sites of interstitial inflammatory cell infiltrates. In
control experiments, normal rabbit serum did not show reactivity to
infected hamster kidney sections. Uninfected hamster kidney sections
were used as controls in a previous study using antisera to three other
leptospiral proteins (OmpL1, LipL36, and LipL41), none of which showed
any staining of uninfected kidney (3).
|
Humoral immune response to leptospiral proteins in patients with
leptospirosis.
Convalescent sera from five patients with
culture-proven infection due to L. kirschneri serovar bim
were used to compare the ELISA reactivity with five leptospiral
His6 fusion proteins. As shown in Fig.
7, LipL32 and the porin OmpL1 were found
to be stronger leptospiral immunogens during naturally occurring
infection than the three other leptospiral lipoproteins LipL36, LipL41,
or LipL46 (P < 0.05). Control experiments with 62 normal human sera found no significant ELISA reactivity with LipL32
(A. Ko, personal communication).
|
| |
DISCUSSION |
|---|
|
|
|---|
In this study we have characterized LipL32, the most prominent protein in the leptospiral total protein profile, and the major Triton X-114 detergent-phase protein. Extraction of L. kirschneri with the nonionic detergents Triton X-100 or Triton X-114 solubilizes the leptospiral outer membrane, including the LPS, the porin OmpL1, and the lipoproteins LipL36 and Lip41 (15, 16, 18, 31). The specificity of Triton detergent extraction for the outer membrane has been assessed by demonstrating that the leptospiral cell wall and morphology remain intact after extraction and that the control proteins endoflagella, penicillin-binding proteins, and GroEL are not extractable under these conditions. The conclusion that LipL32 is the leptospiral MOMP is consistent with previous findings of a prominent band of approximately the same molecular mass in the protein profiles of leptospiral outer membrane fractions isolated using the technique of Auran et al. (2, 10, 25).
The results of the studies presented here differ in significant ways from previously published reports analyzing leptospiral outer membrane proteins by detergent extraction. Although, in an earlier study, a 32-kDa major protein was apparent in the total protein profile of L. kirschneri, it was absent from the Triton X-114 detergent phase because CaCl2 was not included during the phase-partitioning step (18). In a study published at approximately the same time on the closely related organism L. interrogans, Zuerner et al. demonstrated that CaCl2, ZnCl2, or CuCl2 must be present during the phase-partitioning step to prevent the loss of LipL32 from the Triton X-114 detergent phase (41). In the current study, we have demonstrated that these are properties of LipL32 by using antiserum specific for this protein (Fig. 4), which was made possible by the isolation of the lipL32 gene and the generation of purified recombinant protein used to immunize rabbits.
The CaCl2 requirement for stability of LipL32 is not understood. Zuerner et al. proposed that the loss of LipL32 during Triton X-114 phase partitioning is due to degradation by an endogenous protease (41). In this study, we found that CaCl2 is not required until the temperature is raised to 37°C to separate the Triton X-114 extract into aqueous and detergent phases. Neither temperature nor Triton X-114 are sufficient alone to degrade LipL32. Presumably, the combination of heat and detergent result in denaturation of LipL32, which in turn exposes sites sensitive to proteolytic degradation. We were unable to determine whether or not LipL32 was autocatalytic, since attempts to reproduce LipL32 degradation using an in vitro-synthesized protein were unsuccessful. The protective effect of CaCl2 could operate in several ways. It is possible that Ca2+ binding is required for conformational stability of LipL32. On the other hand, the finding that several Triton X-114 detergent-phase proteins other than LipL32 are also partially or completely lost from the Triton X-114 extract during phase partitioning without CaCl2 (Fig. 4) suggests that the mechanism of Ca2+ stabilization is indirect. For example, either the putative protease is inhibited by Ca2+ or leptospiral phospholipids and/or LPS associated with leptospiral outer membrane proteins require CaCl2 for their stability. This latter explanation would be consistent with the role of divalent cations in maintaining the integrity of the E. coli outer membrane. Based on this idea, it would be anticipated that calcium chelators, such as EDTA, would destabilize the leptospiral outer membrane. Further studies to elucidate the protective mechanism of CaCl2 would shed light on leptospiral outer membrane structure and the interaction of leptospiral outer membrane proteins with other outer membrane components.
Another important aspect of the method described here is the inclusion of 150 mM NaCl in the buffer used in the initial extraction at 4°C with Triton X-114. Previous studies that did not include 150 mM NaCl in the extraction buffer found that Triton detergent extraction of proteins such as OmpL1 and LipL41 was incomplete (15, 16, 31). NaCl is probably important in the solubility of these and potentially other leptospiral outer membrane proteins. On the basis of the findings in this study, we believe that the method of Triton X-114 extraction and phase partitioning described here and in the study by Zuerner et al. (41) results in isolation of fractions which most accurately represent the components of the leptospiral outer membrane. We have not excluded the possibility that some cytoplasmic membrane proteins are extractable under these conditions. Confirmation of the Triton X-114 solubilization and phase-partitioning approach will require the development of better markers for the cytoplasmic membrane and independent approaches for the separation of the cytoplasmic membrane from the outer membrane.
In this study, we have presented several lines of evidence to support the conclusion that LipL32 is a lipoprotein, covalently modified by fatty acid(s) at its amino-terminal cysteine residue. The atypical lipoprotein signal peptidase cleavage site of LipL32 and the inefficient cleavage of LipL32 expressed in E. coli (data not shown) are consistent with the idea that the leptospiral lipoprotein signal peptidase and/or other components of the leptospiral membrane protein export pathway differ in their specificity from those of E. coli (D. A. Haake, submitted for publication). Even though the two other lipoproteins that have been described in Leptospira species, LipL36 and LipL41, have an L-X-Y-C lipoprotein signal peptidase cleavage site, they are also inefficiently processed in E. coli unless the amino acids between leucine and cysteine are altered to conform to those found in the E. coli murein lipoprotein (17). Like LipL36 and LipL41, LipL32 is labeled by intrinsic labeling of L. kirschneri by [3H]palmitate. Previous [3H]palmitate labeling studies of leptospiral lipoproteins were subject to the criticism that the tritium label could have been incorporated into amino acids through beta-oxidation of [3H]palmitate. In this study, we have shown that in the process of staining LipL32 with Coomassie brilliant blue and treatment with 10% acetic acid, the tritium label is lost. This is consistent with an acid-labile bond between palmitate and the N-terminal cysteine, a pattern found in other spirochetal lipoproteins (8, 33). Another form of evidence that LipL32 is a lipoprotein is its behavior during Triton X-114 phase partitioning. Native LipL32 partitions selectively into the hydrophobic detergent phase, a result consistent with modification by hydrophobic fatty acids, while the recombinant His6-LipL32 fusion protein lacking N-terminal lipidation partitions into the hydrophilic aqueous phase (data not shown).
Although there is a discrepancy of >4 kDa between the observed mobility of LipL32 and its calculated molecular mass of 27.6 kDa, we believe that the lipL32 sequence data we have presented are correct. The >99% nucleotide sequence identity between the L. kirschneri LipL32 and other versions of LipL32 make it unlikely that there were internal deletions during the cloning process. The location of the TAA stop codon is confirmed by the inverted repeat located 23 bp downstream. A likely explanation for the slower-than-predicted electrophoretic mobility of LipL32 is the high percentage of acidic residues (34 of 253 [13.4%]), which could reduce SDS binding. Leptospiral LipL41 (31) and the T. pallidum lipoprotein TpN34 (34) are two other examples of lipoproteins with high percentages of acidic residues associated with discrepancies between the observed electrophoretic mobility and the calculated molecular mass.
Our findings indicate that LipL32 is expressed at high levels both during cultivation and during infection. Some proteins found in organisms grown in leptospiral culture conditions are not expressed during infection. For example, LipL36 is expressed at high levels by cultivated L. kirschneri but is not detectable either within infected hamster kidneys by immunohistochemistry or by sera from hamsters infected with host-derived organisms (3, 16). In contrast, OmpL1 and LipL41 were detectable both by immunohistochemistry and by immunoblot (3). The immunohistochemistry results presented here indicate that, like OmpL1 and LipL41, LipL32 is expressed by L. kirschneri within renal tubules (Fig. 6). In addition, sera from humans with leptospirosis had a stronger antibody response to LipL32 than to the four other leptospiral membrane proteins (Fig. 7). These results suggest that LipL32 may be useful in the development of new approaches for the serological diagnosis of leptospirosis. Further studies are needed to define the time course of the humoral immune response to LipL32 during the course of leptospirosis. Research on outer membrane proteins expressed by Leptospira spp. during infection is essential both to an understanding of leptospiral pathogenesis and for development of subunit vaccines. It is anticipated that the reagents and findings developed during the course of this investigation will make it possible to elucidate the role of LipL32 in the interaction of pathogenic Leptospira spp. with the mammalian host.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by funding from a Public Health Service grant AI-34431 (to D.A.H.).
We thank Tonia McNunn and Annette Olson for excellent technical assistance.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Division of Infectious Diseases, 111F, VA Greater LA Healthcare System, Los Angeles, CA 90073. Phone: (310) 478-3711, x40267. Fax: (310) 268-4928. E-mail: dhaake{at}ucla.edu.
Editor: P. E. Orndorff
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Altschul, S. F.,
T. L. Madden,
A. A. Schaffer,
J. Zhang,
Z. Zhang,
W. Miller, and D. J. Lipman.
1997.
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
Nucleic Acids Res.
25:3389-3402 |
| 2. |
Auran, N. E.,
R. C. Johnson, and D. M. Ritzi.
1972.
Isolation of the outer sheath of Leptospira and its immunogenic properties in hamsters.
Infect. Immun.
5:968-975 |
| 3. |
Barnett, J. K.,
D. Barnett,
C. A. Bolin,
T. A. Summers,
E. A. Wagar,
N. F. Cheville,
R. A. Hartskeerl, and D. A. Haake.
1999.
Expression and distribution of leptospiral outer membrane components during renal infection of hamsters.
Infect. Immun.
67:853-861 |
| 4. | Bergstrom, S., V. G. Bundoc, and A. G. Barbour. 1989. Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi. Mol. Microbiol. 3:479-486[CrossRef][Medline]. |
| 5. | Bolin, C. A., J. A. Cassells, R. L. Zuerner, and G. Trueba. 1991. Effect of vaccination with a monovalent Leptospira interrogans serovar hardjo type hardjo-bovis vaccine on type hardjo-bovis infection of cattle. Am. J. Vet. Res. 52:1639-1643[Medline]. |
| 6. | Bolin, C. A., A. B. Thiermann, A. L. Handsaker, and J. W. Foley. 1989. Effect of vaccination with a pentavalent leptospiral vaccine on Leptospira interrogans serovar hardjo type hardjo-bovis infection of pregnant cattle. Am. J. Vet. Res. 50:161-165[Medline]. |
| 7. | Bolin, C. A., R. L. Zuerner, and G. Trueba. 1989. Effect of vaccination with a pentavalent leptospiral vaccine containing Leptospira interrogans serovar hardjo type hardjo-bovis on type hardjo-bovis infection of cattle. Am. J. Vet. Res. 50:2004-2008[Medline]. |
| 8. |
Brandt, M. E.,
B. S. Riley,
J. D. Radolf, and M. V. Norgard.
1990.
Immunogenic integral membrane proteins of Borrelia burgdorferi are lipoproteins.
Infect. Immun.
58:983-991 |
| 9. |
Brenner, D. J.,
A. F. Kaufmann,
K. R. Sulzer,
A. G. Steigerwalt,
F. C. Rogers, and R. S. Weyant.
1999.
Further determination of DNA relatedness between serogroups and serovars in the family Leptospiraceae with a proposal for Leptospira alexanderi sp. nov. and four new Leptospira genomospecies.
Int. J. Syst. Bacteriol.
49(Pt. 2):839-858 |
| 10. |
Brown, J. A.,
R. B. LeFebvre, and M. J. Pan.
1991.
Protein and antigen profiles of prevalent serovars of Leptospira interrogans.
Infect. Immun.
59:1772-1777 |
| 11. | Burman, N., S. Bergstrom, B. I. Restrepo, and A. G. Barbour. 1990. The variable antigens Vmp7 and Vmp21 of the relapsing fever bacterium Borrelia hermsii are structurally analogous to the VSG proteins of the African trypanosome. Mol. Microbiol. 4:1715-1726[CrossRef][Medline]. |
| 12. |
Chamberlain, N. R.,
M. E. Brandt,
A. L. Erwin,
J. D. Radolf, and M. V. Norgard.
1989.
Major integral membrane protein immunogens of Treponema pallidum are proteolipids.
Infect. Immun.
57:2872-2877 |
| 13. |
Chamberlain, N. R.,
L. DeOgny,
C. Slaughter,
J. D. Radolf, and M. V. Norgard.
1989.
Acylation of the 47-kilodalton major membrane immunogen of Treponema pallidum determines its hydrophobicity.
Infect. Immun.
57:2878-2885 |
| 14. | Garnier, J., J.-F. Gibrat, and B. Robson. 1996. GOR secondary structure prediction method version IV. Methods Enzymol. 266:540-553[Medline]. |
| 15. |
Haake, D. A.,
C. I. Champion,
C. Martinich,
E. S. Shang,
D. R. Blanco,
J. N. Miller, and M. A. Lovett.
1993.
Molecular cloning and sequence analysis of the gene encoding OmpL1, a transmembrane outer membrane protein of pathogenic Leptospira spp.
J. Bacteriol.
175:4225-4234 |
| 16. |
Haake, D. A.,
C. Martinich,
T. A. Summers,
E. S. Shang,
J. D. Pruetz,
A. M. McCoy,
M. K. Mazel, and C. A. Bolin.
1998.
Characterization of leptospiral outer membrane lipoprotein LipL36: downregulation associated with late-log-phase growth and mammalian infection.
Infect. Immun.
66:1579-1587 |
| 17. |
Haake, D. A.,
M. K. Mazel,
A. M. McCoy,
F. Milward,
G. Chao,
J. Matsunaga, and E. A. Wagar.
1999.
Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection.
Infect. Immun.
67:6572-6582 |
| 18. |
Haake, D. A.,
E. M. Walker,
D. R. Blanco,
C. A. Bolin,
M. N. Miller, and M. A. Lovett.
1991.
Changes in the surface of Leptospira interrogans serovar grippotyphosa during in vitro cultivation.
Infect. Immun.
59:1131-1140 |
| 19. | Hayashi, S., and H. C. Wu. 1990. Lipoproteins in bacteria. J. Bioenerg. Biomembr. 22:451-471[CrossRef][Medline]. |
| 20. |
Hookey, J. V.,
J. Bryden, and L. Gatehouse.
1993.
The use of 16S rDNA sequence analysis to investigate the phylogeny of Leptospiaceae and related spirochaetes.
J. Gen. Microbiol.
139(Pt. 11):2585-2590 |
| 21. |
Johnson, R. C., and V. G. Harris.
1967.
Differentiation of pathogenic and saprophytic letospires. I. Growth at low temperatures.
J. Bacteriol.
94:27-31 |
| 22. | Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685[CrossRef][Medline]. |
| 23. |
Marqusee, S., and R. L. Baldwin.
1987.
Helix stabilization by Glu ...Lys+ salt bridges in short peptides of de novo design.
Proc. Natl. Acad. Sci. USA
84:8898-8902 |
| 24. | Miller, J. H. 1992. A short course in bacterial genetics: a laboratory manual and handbook for Escherichia coli and related bacteria. Cold Spring Harbor Laboratory Press, Plainview, N.Y. |
| 25. |
Nunes-Edwards, P. L.,
A. B. Thiermann,
P. J. Bassford, Jr., and L. V. Stamm.
1985.
Identification and characterization of the protein antigens of Leptospira interrogans serovar hardjo.
Infect. Immun.
48:492-497 |
| 26. |
Pugsley, A. P.
1993.
The complete general secretory pathway in gram-negative bacteria.
Microbiol. Rev.
57:50-108 |
| 27. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 28. | Schagger, H., and G. von Jagow. 1987. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem. 166:368-379[CrossRef][Medline]. |
| 29. | Shang, E. S., M. M. Exner, T. A. Summers, C. Martinich, C. I. Champion, R. E. W. Hancock, and D. A. Haake. 1995. The rare outer membrane protein, OmpL1, of pathogenic Leptospira species is a heat-modifiable porin. Infect. Immun. 63:3174-3181[Abstract]. |
| 30. |
Shang, E. S.,
J. T. Skare,
M. M. Exner,
D. R. Blanco,
B. L. Kagan,
J. N. Miller, and M. A. Lovett.
1998.
Isolation and characterization of the outer membrane of Borrelia hermsii.
Infect. Immun.
66:1082-1091 |
| 31. | Shang, E. S., T. A. Summers, and D. A. Haake. 1996. Molecular cloning and sequence analysis of the gene encoding LipL41, a surface-exposed lipoprotein of pathogenic Leptospira species. Infect. Immun. 64:2322-2330[Abstract]. |
| 32. | Steiner, G., and G. Steiner. 1944. New simple silver stain for demonstration of bacteria, spirochetes, and fungi in sections of paraffin-embedded tissue blocks. J. Lab. Clin. Med. 29:868-871. |
| 33. |
Swancutt, M. A.,
J. D. Radolf, and M. V. Norgard.
1990.
The 34-kilodalton membrane immunogen of Treponema pallidum is a lipoprotein.
Infect. Immun.
58:384-392 |
| 34. |
Swancutt, M. A.,
B. S. Riley,
J. D. Radolf, and M. V. Norgard.
1989.
Molecular characterization of the pathogen-specific, 34-kilodalton membrane immunogen of Treponema pallidum.
Infect. Immun.
57:3314-3323 |
| 35. | Thiermann, A. B. 1984. Leptospirosis: current developments and trends. J. Am. Vet. Med. Assoc. 184:722-725[Medline]. |
| 36. | Thiermann, A. B., R. D. McClellan, and H. T. Hill. 1984. Improved techniques for the isolation of leptospires from swine abortion cases. Ann. Proc. Am. Assoc. Vet. Lab. Diagn. 27:233-244. |
| 37. |
Thomas, W., and R. Sellwood.
1993.
Molecular cloning, expression, and DNA sequence analysis of the gene that encodes the 16-kilodalton outer membrane lipoprotein of Serpulina hyodysenteriae.
Infect. Immun.
61:1136-1140 |
| 37a. |
Thompson, J. D.,
T. J. Gibson,
F. Plewniak,
F. Jeanmougin, and D. G. Higgins.
1997.
The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.
Nucleic Acids Res.
25:4876-4882 |
| 38. |
Weigel, L. M.,
J. T. Belisle,
J. D. Radolf, and M. V. Norgard.
1994.
Digoxigenin-ampicillin conjugate for detection of penicillin-binding proteins by chemiluminescence.
Antimicrob. Agents Chemother.
38:330-336 |
| 39. | Yelton, D. B., and N. W. Charon. 1984. Cloning of a gene required for tryptophan biosynthesis from Leptospira biflexa serovar patoc into Escherichia coli. Gene 28:147-152[CrossRef][Medline]. |
| 40. |
Zuerner, R. L.,
J. L. Herrmann, and I. Saint Girons.
1993.
Comparison of genetic maps for two Leptospira interrogans serovars provides evidence for two chromosomes and intraspecies heterogeneity.
J. Bacteriol.
175:5445-5451 |
| 41. | Zuerner, R. L., W. Knudtson, C. A. Bolin, and G. Trueba. 1991. Characterization of outer membrane and secreted proteins of Leptospira interrogans serovar pomona. Microb. Pathog. 10:311-322[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»